Treatment of Otitis Externa in Children with Ear Tubes
First-Line Treatment
- The American Academy of Otolaryngology-Head and Neck Surgery recommends topical antibiotic ear drops, specifically ofloxacin or ciprofloxacin-dexamethasone, administered twice daily for 10 days, as the first-line treatment for otitis externa in children with tympanostomy tubes 1, 2
- Topical antibiotic ear drops have demonstrated superior outcomes compared to systemic antibiotics, with clinical cure rates of 77-96% versus 30-67% for oral antibiotics 2, 3
Administration Technique
- The American Academy of Otolaryngology-Head and Neck Surgery suggests cleaning any drainage or debris from the ear canal before administering drops using a cotton-tipped swab dipped in hydrogen peroxide or warm water, a cotton ball to absorb drainage, gentle suction with an infant nasal aspirator, or tissue spears to assist in cleaning 1, 2
Why Topical Treatment is Superior
- Topical therapy provides significantly higher drug concentration at the infection site (up to 1000 times higher than systemic therapy) and better coverage of likely pathogens, especially Pseudomonas aeruginosa and Staphylococcus aureus 2, 4, 5
- Topical therapy avoids adverse events associated with systemic antibiotics, including dermatitis, allergic reactions, gastrointestinal upset, oral thrush, and increased antibiotic resistance 2, 4
Water Precautions During Treatment
- The American Academy of Otolaryngology-Head and Neck Surgery recommends preventing water entry into the ear canal during bathing or hair washing and using a piece of cotton saturated with Vaseline to cover the ear canal opening 1
- No swimming is recommended until the drainage stops 1
When to Consider Systemic Antibiotics
- The American Academy of Otolaryngology-Head and Neck Surgery suggests considering oral antibiotics when the infection has spread beyond the ear canal, the child is very ill, the child has another reason to be on an antibiotic, or the infection does not improve after using ear drops 1, 2, 4, 6
Important Cautions
- The American Academy of Otolaryngology-Head and Neck Surgery recommends using only topical drops approved for use with tympanostomy tubes (ofloxacin or ciprofloxacin-dexamethasone) to avoid potential ototoxicity from aminoglycoside-containing eardrops 2, 6
- Limiting topical therapy to a single course of no more than 10 days is recommended to avoid fungal external otitis 1, 2
Follow-up Recommendations
- The American Academy of Otolaryngology-Head and Neck Surgery suggests reassessment if symptoms persist beyond 7 days despite appropriate treatment and considering culturing persistent drainage to detect resistant pathogens such as MRSA or fungi 2, 7
- Routine follow-up with a physician every 4-6 months is important to ensure tubes are in place and functioning properly 1
Guideline Recommendations for Ear Drops in Tympanostomy Tubes
First‑Line Topical Therapy
- Quinolone ear drops (ofloxacin or ciprofloxacin, with or without dexamethasone) are the only ear drops recommended for ears with tympanostomy tubes, according to the American Academy of Otolaryngology‑Head and Neck Surgery (AAO‑HNS) guidelines. 8
- Topical quinolone therapy achieves drug concentrations roughly 1,000‑fold higher at the infection site than oral antibiotics, providing superior antimicrobial exposure. 9
- Clinical cure rates with topical quinolones range from 77 % to 96 %, compared with 30 % to 67 % for oral antibiotics. 9
- Quinolone drops cover the most common otitis media pathogens: Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. 9
Administration Technique
- The ear canal must be cleaned of debris or discharge before instilling drops; otherwise medication cannot reach the middle ear through the tube. 9
- After placing drops, the tragus should be “pumped” four times to facilitate penetration of the medication through the tube into the middle ear. 9
Treatment Duration and Prophylaxis
- Routine prophylactic ear drops after tube placement are not recommended. 8
Indications for Adding Oral Antibiotics
- Add oral antibiotics if cellulitis of the pinna or adjacent skin develops. 9
- Add oral antibiotics for concurrent bacterial infections (e.g., sinusitis, pneumonia, streptococcal pharyngitis). 9
- Add oral antibiotics when there are signs of severe infection (high fever, severe pain, toxic appearance). 9
- Add oral antibiotics if otorrhea persists or worsens after 7 days of topical therapy. 9
- Add oral antibiotics in immunocompromised children. 9
Comparative Effectiveness
- Topical quinolone therapy is superior to oral antibiotics as first‑line treatment for uncomplicated tube otorrhea. [8][9]
First‑Line Management of Tube‑Related Otorrhea in Children
Recommended First‑Line Therapy
- The American Academy of Otolaryngology‑Head and Neck Surgery recommends using topical fluoroquinolone ear drops (ofloxacin 0.3% or ciprofloxacin‑dexamethasone 0.2%) twice daily for 7–10 days as the initial treatment for uncomplicated otorrhea associated with tympanostomy tubes; oral antibiotics should not be prescribed in this setting. 10
Efficacy and Pharmacokinetics
- In pediatric patients with tympanostomy tubes and acute otorrhea, topical antibiotic drops achieve clinical cure rates of 77 %–96 %, whereas oral antibiotics achieve only 30 %–67 % cure rates. 10
- Topical administration delivers drug concentrations at the infection site that are approximately 1,000‑fold higher than those achieved with oral therapy, providing superior antimicrobial exposure directly where the infection resides. 10
Pathogen Coverage
- The most frequent causative organisms in tube‑related otorrhea are Pseudomonas aeruginosa and Staphylococcus aureus; both are effectively covered by the recommended topical fluoroquinolones. 10
Safety Profile
- Topical fluoroquinolone therapy avoids systemic adverse effects such as dermatitis, gastrointestinal upset, oral thrush, and the development of systemic antibiotic resistance that are associated with oral antibiotics. 10
Approved Topical Agents and Contraindicated Drops
- Ofloxacin 0.3% otic solution and ciprofloxacin‑dexamethasone 0.2% are the only ear‑drop formulations approved for use with tympanostomy tubes. 10
- These fluoroquinolone preparations have been shown to be non‑ototoxic even when they reach the middle ear through the tube. 10
- Aminoglycoside‑containing drops (e.g., neomycin/polymyxin B) are ototoxic when they enter the middle ear and must never be used in children with tubes. 10
Administration Protocol
- Prior to drop instillation, the ear canal should be cleaned of drainage or debris using a cotton‑tipped swab moistened with hydrogen peroxide or warm water.
- In children, the ear is pulled backward and upward to straighten the canal, and after each dose the tragus is “pumped” four times to promote medication passage through the tube.
- Drops are applied twice daily for 7–10 days, and treatment should be limited to a single course of ≤10 days to reduce the risk of fungal overgrowth. 10
Indications for Adding Systemic Antibiotics
| Situation | Recommended Systemic Agent (if needed) |
|---|---|
| Cellulitis extending beyond the ear canal (involving pinna or adjacent skin) | – |
| High fever (≥ 38.5 °C) with systemic illness | – |
| Concurrent bacterial infection requiring systemic therapy (e.g., streptococcal pharyngitis, bacterial sinusitis, pneumonia) | – |
| Otorrhea persisting or worsening after 7 days of appropriate topical therapy | – |
| Immunocompromised status | – |
- When systemic therapy is indicated for typical otitis media pathogens (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis), high‑dose amoxicillin (80–90 mg/kg/day divided BID) is the first‑line oral agent.
- If coverage for Pseudomonas is required after topical failure, oral fluoroquinolones may be considered in consultation with a specialist. 10
Risks of Inappropriate Oral Antibiotic Use
- Despite evidence favoring topical therapy, oral antibiotics are inappropriately prescribed as initial treatment in 20 %–40 % of uncomplicated tube‑related otorrhea cases. 10
Duration Limits and Fungal Risk
- Continuous use of quinolone ear drops for more than 10 days increases the risk of otomycosis (fungal ear infection). 10